Skip to content
-
Read the Latest Issue of The Advocate!
Jun 11
This issue highlights notable news and happenings across the industry and our organization. Click here to... read more
-
Corporate Member Spotlight: Thompson Solutions
Jun 08
NASP is pleased to shine the Spotlight on Thompson Solutions, a corporate member of the month.... read more
-
NASP Submits Comments on the Proposed HCPCS Coding Changes for Immune Globulin Products
Jun 03
On June 3, NASP submitted comments urging CMS to reconsider its proposed HCPCS coding changes for... read more
-
NASP Podcast Episode – Collaboration that can Help Change Care: Pharmacists and ATTR-CM Identification
May 21
In this episode, Sheila Arquette, President & CEO of NASP, speaks with Marina Carter, PharmD, BCACP,... read more
-
NASP Submits Comments on 340B Rebate Model Pilot Program
Apr 21
On April 20, NASP submitted comments to the Health Resources and Services Administration’s (HRSA) urging the... read more
-
Read the Latest Issue of The Advocate – 2026; Vol. 1
Mar 13
This issue of The Advocate highlights notable news and happenings across the industry and our organization. The Advocate is... read more
-
NASP Submits Comments on Producer Responsibility Packaging and Paper Products Regulations
Mar 05
NASP submitted comments on the proposed COMAR 26.04.14 – Packaging and Paper Products – Producer Responsibility.... read more
-
Corporate Member Spotlight: Claritas Rx
Mar 02
NASP is pleased to shine the Spotlight on Claritas Rx, a corporate member of the month.... read more
-
NASP Submits Comments on Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model
Feb 26
In comments on CMS’s proposed GUARD Model for Medicare Part D, NASP cautioned that the international... read more
-
NASP Submits Comments on Proposed Regulations for Global Benchmark for Efficient Drug Pricing (GLOBE) Model; Proposed Rule (90 FR 60244)
Feb 26
In comments on CMS’s proposed Global Benchmark for Efficient Drug Pricing (GLOBE) Model, NASP urged revisions... read more